2022 IADR/APR General Session
The 100 th General Session & Exhibition of the IADR was held in conjunction with the 5th Meeting of the Asia Pacific Region. The virtual meeting was attended by individuals from around the world. Those attending the meeting could choose from among 207 Interactive Talk sessions, seven Focused Learning Sessions, three Hands-on Workshops, five satellite symposia, 52 Symposia, one Distinguished Lecture Series and a plenary.The recordings in this library from the meeting are a selection of the science that was to be presented as part of the General Session. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include the IADR Distinguished Lecture Series speaker and symposia from a collection of scientific groups and networks.
This session can be purchased as part of the full meeting recordings within the product bundles
The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Session Description
The global public health issue of antimicrobial Resistance is a silent pandemic that needs to be tackled immediately. The dental community has an opportunity to contribute to global efforts to tackle antibiotic resistance by promoting appropriate antibiotic use. Antibiotic stewardship and the availability and use of evidence-based prescribing guidelines are key, especially during COVID-19 pandemic when antibiotic prescriptions have substantially increased, as shown in studies of dental prescribing in some countries, including England. Understanding the factors that influence prescribing, and the effect of the COVID-19 pandemic on the dental prescribing of antibiotics are important when developing antibiotic stewardship interventions. In addition, knowing what outcomes are best to measure and report in stewardship interventions is also important when developing stewardship programmes, in order to enable comparison between different programmes and locations. The session will explore trends of antibiotics prescribing during the COVID-19 pandemic in different countries. Secondly, an international consensus to measure the core outcomes that should be reported in dental antibiotic stewardship programmes will also be presented. Finally, initial results from a review of the antibiotic prescription guidelines available in the Latin American region, which is needed to understand the current availability of evidence-based guidance and international variations of antibiotics use.
Learning Objectives
June 23, 2022
Presenters
Wendy Thompson - Core Outcomes in Antibiotic Stewardship: an International Consensus
Leanne Teoh - Understanding Antibiotic Prescribing and the COVID-19 Effect
Paula Anabalon - Antibiotic Prescription Guidelines: a Global Need in Dentistry
Sponsoring Groups/Networks
Behavioral, Epidemiologic, and Health Services Research, Evidence-based Dentistry Network, Pharmacology/Therapeutics/Toxicology, Women in Science Network
CE Credits
1.5 Hours
Financial Interest Disclosure:
GSK provides an unrestricted educational grant. Funds of this grant may be used to cover speakers travel.
Supported by:
GlaxoSmithKline (GSK)
The global public health issue of antimicrobial Resistance is a silent pandemic that needs to be tackled immediately. The dental community has an opportunity to contribute to global efforts to tackle antibiotic resistance by promoting appropriate antibiotic use. Antibiotic stewardship and the availability and use of evidence-based prescribing guidelines are key, especially during COVID-19 pandemic when antibiotic prescriptions have substantially increased, as shown in studies of dental prescribing in some countries, including England. Understanding the factors that influence prescribing, and the effect of the COVID-19 pandemic on the dental prescribing of antibiotics are important when developing antibiotic stewardship interventions. In addition, knowing what outcomes are best to measure and report in stewardship interventions is also important when developing stewardship programmes, in order to enable comparison between different programmes and locations. The session will explore trends of antibiotics prescribing during the COVID-19 pandemic in different countries. Secondly, an international consensus to measure the core outcomes that should be reported in dental antibiotic stewardship programmes will also be presented. Finally, initial results from a review of the antibiotic prescription guidelines available in the Latin American region, which is needed to understand the current availability of evidence-based guidance and international variations of antibiotics use.
Learning Objectives
- Learn about the development of international consensus on a Core Outcome Set for Dental Antibiotic Stewardship to maximize the derivable benefit from future studies.
- Understand the changes in antibiotic prescribing due to the COVID-19 pandemic.
- Investigate the evidence-base and variations among different antibiotic prescribing guidelines for dental care available in the Latin American region.
June 23, 2022
Presenters
Wendy Thompson - Core Outcomes in Antibiotic Stewardship: an International Consensus
Leanne Teoh - Understanding Antibiotic Prescribing and the COVID-19 Effect
Paula Anabalon - Antibiotic Prescription Guidelines: a Global Need in Dentistry
Sponsoring Groups/Networks
Behavioral, Epidemiologic, and Health Services Research, Evidence-based Dentistry Network, Pharmacology/Therapeutics/Toxicology, Women in Science Network
CE Credits
1.5 Hours
GSK provides an unrestricted educational grant. Funds of this grant may be used to cover speakers travel.
GlaxoSmithKline (GSK)
Not eligible for individual purchase; must purchased as part of a meeting bundle.
